Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Mitchell

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Cancer|October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lungJ Y Killen, E P Mitchell, D F Hoth, et al.
Missouri Medicine|May 1, 1985
An analysis of the histologic evaluation of lung cancerR D Reynolds, A Khojasteh, E P Mitchell, et al.
Journal of Colloid and Interface Science|July 15, 2019
Towards a molecular understanding of the water purification properties of Moringa seed proteinsM Moulin, E Mossou, L Signor, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1996
A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B studyE P Mitchell, M C Perry, S D Luikart, et al.
Diseases of the Colon and Rectum|February 1, 1994
Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical managementM L Corman, S Galandiuk, G E Block, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 1, 1995
Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selectionK A Watson, E P Mitchell, L N Johnson, et al.
Biochemistry|May 17, 1994
Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compoundsK A Watson, E P Mitchell, L N Johnson, et al.
Radiology|October 1, 1992
Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CTB D Collier, H Abdel-Nabi, R J Doerr, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1994
The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylaseN G Oikonomakos, M Kontou, S E Zographos, et al.
Cancer Research|July 1, 1986
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsyF M Torti, M M Bristow, B L Lum, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cancer|October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lungJ Y Killen, E P Mitchell, D F Hoth, et al.
Missouri Medicine|May 1, 1985
An analysis of the histologic evaluation of lung cancerR D Reynolds, A Khojasteh, E P Mitchell, et al.
Journal of Colloid and Interface Science|July 15, 2019
Towards a molecular understanding of the water purification properties of Moringa seed proteinsM Moulin, E Mossou, L Signor, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1996
A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B studyE P Mitchell, M C Perry, S D Luikart, et al.
Diseases of the Colon and Rectum|February 1, 1994
Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical managementM L Corman, S Galandiuk, G E Block, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 1, 1995
Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selectionK A Watson, E P Mitchell, L N Johnson, et al.
Biochemistry|May 17, 1994
Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compoundsK A Watson, E P Mitchell, L N Johnson, et al.
Radiology|October 1, 1992
Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CTB D Collier, H Abdel-Nabi, R J Doerr, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1994
The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylaseN G Oikonomakos, M Kontou, S E Zographos, et al.
Cancer Research|July 1, 1986
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsyF M Torti, M M Bristow, B L Lum, et al.
Pageof 5